Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aloe Vera + Dutasteride in BPH
NCT07065682Phase 1Recruiting
- Sponsor
- Diponegoro University
- Start
- Jul 2023
- Primary completion
- Dec 2024
- Modality
- PE (Plant Extract)
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of aloe vera in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Diponegoro University. Primary endpoint: Uroflowmetry result at 12 weeks. Started Jul 2023; status: recruiting.
02
Drugs
aloe vera
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT07065682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07065682.